By Market & Region

Pune, India – September 24, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

Disease-modifying therapies and biologics drive current market expansion

Rising MS prevalence, improved diagnostic capabilities, and growing adoption of immunomodulators, immunosuppressants, interferons, oral disease-modifying therapies (DMTs), and monoclonal antibodies are fueling demand across relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and clinically isolated syndrome (CIS) patient segments. High-efficacy biologics and oral treatment options are increasingly displacing older therapy classes as patients and physicians prioritize convenience and disease-progression control.

Pune, India – September 24, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.

Asia-Pacific leads global demand as Japan, South Korea and China drive placenta research

Asia-Pacific held the leading market position in 2025, backed by strong placenta research and development in Japan, South Korea and China, alongside rising production of placenta-derived products for pharmaceutical and cosmetics applications. The region's large consumer base and appetite for anti-aging and skincare solutions continue to underpin its dominant position.

Austin, Texas – September 24, 2026 -- Forge AI Deployment has committed $30 million to webAI to build and deploy private, specialized AI systems for enterprise customers, the companies announced.

Forge pairs $30 million commitment with webAI's collaborative intelligence platform

The deal combines webAI's technology with Forge's enterprise deployment and services operation. Forge will work directly with customers to build AI systems around proprietary data, workflows and operations, running on infrastructure those customers control, from individual specialized AI Personas to company-wide deployments.

Washington – September 24, 2026 -- State insurance regulators leading the National Association of Insurance Commissioners (NAIC) responded to a letter from U.S. Senator Elizabeth Warren (D-Mass.) by detailing a series of capital and oversight changes made in recent years to address insurers' shifting investment strategies, ownership structures, and risk-transfer arrangements.

Regulators impose a 45% risk-based capital charge on structured security residuals

Pune – September 24, 2026 -- The global bioinformatics market is projected to expand from $20.34 billion in 2025 to $64.60 billion by 2034, a 13.7% compound annual growth rate, according to new analysis from Maximize Market Research.

Genomic data volumes and NGS adoption fuel core demand

Rising volumes of genomic and biological data, driven by expanding next-generation sequencing (NGS) adoption, are pushing pharmaceutical and biotechnology companies toward advanced bioinformatics platforms, sequencing data analysis tools, and biological databases. Declining sequencing costs are drawing smaller research institutions into the market, while growing precision medicine applications are increasing demand for pharmacogenomics, biomarker analysis, and genomic diagnostics.

Houston – September 24, 2026 -- CenterPoint Energy has secured a $50 million federal award from the U.S. Department of Energy to fund advanced substation technology upgrades across its Greater Houston service territory, making it one of the first U.S. utilities to deploy Siemens Energy's transmission grid-stabilizing systems.

DOE selects CenterPoint under SPARK program to modernize transmission infrastructure

The funding was awarded through DOE's Speed to Power through Accelerated Reconductoring and other Key Advanced Transmission Technology Upgrades (SPARK) program, which targets modernization of existing electrical infrastructure to meet rising demand and lower electricity costs for roughly 100 million Americans nationwide. CenterPoint said the award will support technology capable of responding rapidly to shifts in electricity demand, helping stabilize service for one of the fastest-growing regions in Texas.

San Antonio – September 24, 2026 -- Sixty-three percent of in-market vehicle shoppers say they will definitely or probably use AI during their next vehicle purchase, while only 29% of dealers report actively adjusting for AI-powered search, according to Cox Automotive's Q2 2026 AI in Auto Retail Tracker. The survey, fielded in May 2026, polled 483 franchise and independent dealership decision-makers and 1,502 consumers planning a vehicle purchase within 12 months.

AI tools now rival automotive websites as a research channel

Cox Automotive found 36% of shoppers now use AI tools for vehicle research, nearly matching the 38% who rely on automotive-specific websites. Among AI users, 26% ask AI to generate questions for dealers and 24% say it makes them feel more prepared for dealership visits, while only 17% cite avoiding dealership staff as a benefit -- indicating AI use is largely preparatory rather than a replacement for dealer interaction.

Atlanta – September 24, 2026 -- Delta Air Lines (NYSE: DAL) has declared a quarterly dividend of $0.2150 per share, its Board of Directors confirmed.

Delta Sets $0.2150 Per-Share Payout for Shareholders

The dividend applies to all shareholders of record as of the close of business on October 15, 2026. Delta will distribute the payment on November 5, 2026.

Carrier Operates 5,500 Daily Flights Across Six Continents

The Atlanta-based airline runs up to 5,500 daily Delta and Delta Connection flights to more than 300 destinations, supported by a workforce of 100,000 employees. Delta carried over 200 million customers in 2025.

Delta Ranked North America's Most On-Time Airline for 2025

Cirium recognized Delta as North America's most on-time carrier last year, while J.D. Power ranked the airline No. 1 in Premium Economy Passenger Satisfaction in 2025.

Reston – September 24, 2026 -- ICF (NASDAQ: ICFI) will release its third-quarter 2026 financial results on Thursday, November 5, 2026, after market close.

ICF sets Nov. 5 webcast to discuss Q3 results with investors

The global solutions and technology provider will host a webcast at 4:30 p.m. Eastern time the same day to walk analysts and institutional investors through the quarterly financials.

Earnings figures will post to ICF's investor site ahead of the call

Full results will be available at ICF's investor relations page before the webcast begins. Analysts and institutional investors can register in advance to receive dial-in credentials and a unique PIN, while general listeners can join the live webcast without registration.

A replay of the webcast will remain accessible for one year following the live event.

Dallas – – September 24, 2026 -- AT&T's board of directors declared a quarterly dividend of $0.2775 per share on the company's common shares, payable Nov. 2, 2026, to stockholders of record as of the close of business Oct. 12, 2026.

AT&T sets preferred stock payouts alongside common dividend

The board also approved quarterly dividends on AT&T's 5.000% Perpetual Preferred Stock, Series A, and its 4.750% Perpetual Preferred Stock, Series C. The Series A dividend totals $312.50 per preferred share, equivalent to $0.3125 per depositary share. The Series C dividend is set at $296.875 per preferred share, or $0.296875 per depositary share.

All dividend classes share the same record and payment dates

Common stock, Series A and Series C preferred stock dividends will all be paid on Nov. 2, 2026, to holders of record at the close of business on Oct. 12, 2026.

Friendswood, Texas – September 24, 2026 -- More than half of atopic dermatitis (AD) patients who used targeted systemic therapies modified treatment because the drugs failed to work, according to a new study published in Dermatology and Therapy by Castle Biosciences, Inc. (Nasdaq: CSTL).

Study finds 55% of systemic therapy users switched due to lack of efficacy

The research surveyed 43 AD patients and caregivers who completed a 32-question assessment at the 2024 National Eczema Association Eczema Expo. Among respondents who had used targeted systemic therapies, 55% reported modifying treatment because of insufficient results. Inadequate skin clearance and persistent itching were cited as the most frequent reasons for switching drugs or adding topical treatments.

Vancouver, BC – September 24, 2026 -- 1911 Gold Corporation has filed a National Instrument 43-101 Technical Report confirming an Inferred Mineral Resource of 3,314,000 tonnes grading 6.68 grams per tonne gold, containing 712,000 ounces, at its 100%-owned Ogama-Rockland Gold Project in southeastern Manitoba.

Updated resource estimate follows August 11 disclosure

The Technical Report, dated September 24, 2026 with an effective date of August 6, 2026, formalizes the 2026 Mineral Resource Estimate first announced by the company on August 11, 2026. It has been filed on SEDAR+ and posted to the company's website. The report was prepared by Tim Maunula, P.Geo, of T. Maunula & Associates Consulting Inc., and Roselyn Yeboah, P.Eng, of 1911 Gold, both designated Qualified Persons under NI 43-101.

McLean, Va. – September 24, 2026 -- Iridium Communications Inc. (Nasdaq: IRDM) stockholders have formally approved the company's acquisition by Rocket Lab Corporation (Nasdaq: RKLB), clearing a critical hurdle for a deal valued at $54.00 per share on a notional basis.

Shareholders back the deal with overwhelming margin

At a special meeting, approximately 99.6% of votes cast supported the merger agreement, representing roughly 81.0% of Iridium's total outstanding common stock entitled to vote. Full voting results will be disclosed in a Form 8-K filing with the U.S. Securities and Exchange Commission.

Deal terms combine cash and stock in collared exchange

Under the agreement, Iridium stockholders will receive $27.00 in cash plus Rocket Lab shares calculated under an exchange ratio subject to a collar, for each share of Iridium common stock held at closing. The combined consideration carries a notional value of $54.00 per Iridium share.

Quanzhou, China – September 24, 2026 -- INLIF LIMITED (Nasdaq: INLF) swung to a net income of $1.01 million in the first half of fiscal year 2026, reversing a $1.98 million net loss in the same period last year, an improvement of approximately $3.0 million.

Net revenue climbed 26.01% to $12.94 million on new intelligent equipment sales

Net revenue rose to $12.94 million from $10.27 million a year earlier. The gain was driven by a $0.60 million increase in manipulator arm sales, including installation and warranty services, plus $3.36 million in new revenue from the company's intelligent equipment business, which had no revenue contribution in the prior-year period. Sales of raw materials and scraps fell $1.27 million as INLIF shifted to a more demand-driven procurement model.

Arlington, Va. – September 24, 2026 -- Info-Tech Research Group has released a new blueprint, Position Your Brand Strategically as a Cost or Value Leader, offering a three-step framework to help organizations resolve strategic ambiguity between cost efficiency and premium differentiation.

Organizations Split Between Cost and Value Models Risk Getting 'Stuck in the Middle'

The blueprint states that cost leaders depend on efficiency, standardization, and disciplined cost control to serve price-sensitive markets, while value leaders rely on innovation, customer experience, and brand strength to command premium pricing. Firms that pursue both without clear tradeoffs risk lacking a sustainable cost advantage or meaningful differentiation, according to the research.

Vancouver – September 24, 2026 -- IM Cannabis Corp. (Nasdaq: IMCC) has closed a registered direct offering, selling 655,000 common shares at US$2.00 apiece for gross proceeds of US$1.31 million before expenses.

Fort Worth, Texas – September 24, 2026 -- The Starr Conspiracy has launched Battle Card Builder, a free tool that generates competitive intelligence on a company and three named competitors in about four minutes, giving B2B tech sales and marketing teams instant access to pricing data, objection handlers and deal strategy without a login or credit card.

Tool runs three of 33 GTM Kernel components using the agency's paid-tier AI pipeline

Battle Card Builder activates the Category, Competitors and Choice Factors modules of The Starr Conspiracy's proprietary GTM Kernel, running the same AI research pipeline and model tier used in its paid client offering. Users select their company and three rivals in an arcade-style interface, verify a work email, and receive a completed report by email.

Dallas – September 24, 2026 -- Taiwan Expo USA 2026 opened at the Kay Bailey Hutchison Convention Center, placing AI Manufacturing and Smart Energy pavilions side by side across a 260-square-meter exhibition space through September 26.

Smart factory ecosystem spans servers to shop floor

The AI Manufacturing Pavilion presents an end-to-end smart factory chain, from AI servers and liquid-cooling systems to edge computing, machine vision, and intelligent control. Aeolus Robotics Taiwan Company Limited is exhibiting a collaborative service robot alongside 3D vision and AI-driven workplace safety tools, demonstrating integrated hardware-software systems for industrial deployment.

San Francisco – September 24, 2026 -- Motorq and Subaru of America have partnered to stream native vehicle telematics directly into fleet management software, eliminating the need for aftermarket hardware starting with model year 2027 vehicles.

Subaru opens embedded vehicle data to U.S. fleet operators for the first time

The integration marks the first instance of Subaru making embedded vehicle data directly accessible to fleet operators in the United States. It also expands Motorq's OEM integration footprint to 13 global automakers and more than 25 brands.

Norwell, Mass. – September 24, 2026 -- The National Organization for Rare Disorders (NORD) has named six companies and nonprofits as 2026 Industry Innovator honorees for delivering first-of-their-kind FDA-approved therapies to patients with rare diseases that affect a fraction of the more than 30 million Americans living with such conditions.

Six FDA approvals mark milestones across ultra-rare indications

Mighty Therapeutics was recognized for FORZINITY, the first therapy for Barth syndrome, a rare mitochondrial disease, shown to improve muscle strength and quality of life. UCB earned recognition for KYGEVVI, the first and only approved treatment for thymidine kinase 2 deficiency in patients whose symptoms began at or before age 12. Fondazione Telethon was honored for Waskyra, a gene therapy for Wiskott-Aldrich syndrome that stands as the first FDA-approved gene therapy for a primary immunodeficiency disorder and the first developed by a nonprofit.